72.11.Z - Research and experimental development on biotechnology
20 - Manufacture of chemicals and chemical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
23 - Manufacture of other non-metallic mineral products
24.4 - Manufacture of basic precious and other non-ferrous metals
36 - Water collection, treatment and supply
39 - Remediation activities and other waste management services
43 - Specialised construction activities
46 - Wholesale trade, except of motor vehicles and motorcycles
70 - Activities of head offices; management consultancy activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Assets | 34 | 46,1 | 30 | -34,9 |
Gross profit (loss) | -71,4 | 16,3 | -13,2 | -180,9 |
Net profit (loss) | -71,4 | 16,3 | -13,2 | -180,9 |
Cash | 12,3 | 19,5 | 19,1 | -2,4 |
Liabilities and provisions for liabilities | 306,8 | 302,6 | 299,7 | -1 |
Net income from sale | 54,9 | 69,1 | 55,7 | -19,4 |
Short time liabilities | 86,9 | 82,8 | 79,9 | -3,5 |
Working assets | 34 | 46,1 | 30 | -34,9 |
Equity capital | -272,8 | -256,5 | -269,7 | -5,1 |
Operating profit (EBIT) | -71,4 | 19,8 | -9,3 | -146,8 |
% | % | % | p.p. | |
Profitability of capital | 26,2 | -6,3 | 4,9 | 11,2 |
Equity capital to total assets | -802,5 | -556,1 | -897,9 | -341,8 |
Gross profit margin | -130 | 23,6 | -23,7 | -47,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 578 | 438 | 523 | 85 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane